
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Marinomed Biotech
Market Cap: €32.7m
A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.
MARI
€17.75
7D
-0.3%
1Y
24.1%
Warimpex Finanz- und Beteiligungs
Market Cap: €26.0m
Operates as a real estate development and investment company in Austria, Germany, Hungary, Russia, and Poland.
WXF
€0.50
7D
-1.4%
1Y
-28.3%